Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 2/2020

01-02-2020 | Ulcerative Colitis | SSAT Plenary Presentation

Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?

Authors: Hassan Ghoz, Alex Kesler, Sanne A. Hoogenboom, Filippo Gavi, Bhaumik Brahmbhatt, John Cangemi, Paul T. Kröner

Published in: Journal of Gastrointestinal Surgery | Issue 2/2020

Login to get access

Abstract

Background

Ulcerative colitis (UC) is primarily medically managed. Colectomy is required in patients with refractory disease or severe complications. Older studies have reported 20-year colectomy rates of over 50%, but recent studies showed decreased rates to 15%. Temporal trends in the use of colectomy in UC over the past decade (when the use of biologics has become widespread) are lacking.

Methods

Case-control study using the National Inpatient Sample database for years of 2007, 2010, 2013, and 2016 was performed. The primary outcome was determining the temporal trends in the use of colectomy in hospitalized patients with UC. Secondary outcomes were determining the total number of admissions for patients with UC and associated trend in inflation-adjusted hospital costs, charge, and length of hospital stay (LOS). Multivariate regression analyses were used to adjust for other co-variables.

Results

443,043 patients with UC were identified, of which 19,208 underwent colectomy in the study period. The mean patient age was 52 years, and 47% were female. Five percent of hospitalized patients with UC underwent colectomy in 2007, while 2.7% of patients with UC had colectomy in 2016, representing a 46% decrease in colectomies in hospitalized patients in the study period. Patients with UC displayed adjusted odds of colectomy of 0.51 (p < 0.01), adjusted additional mean hospital costs decrease by − $2898 (p < 0.01), hospital charges increase by $26,554 (p < 0.01), LOS decrease by − 2.2 days (p < 0.01) in 2016 compared to 2007.

Conclusion

The odds of colectomy in UC patients decreased significantly over the past decade, likely secondary to improved medical care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ng, S.C., et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018. 390(10114): p. 2769–2778.CrossRef Ng, S.C., et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018. 390(10114): p. 2769–2778.CrossRef
2.
go back to reference Baumgart, D.C. and S.R. Carding, Inflammatory bowel disease: cause and immunobiology. Lancet, 2007. 369(9573): p. 1627–40.CrossRef Baumgart, D.C. and S.R. Carding, Inflammatory bowel disease: cause and immunobiology. Lancet, 2007. 369(9573): p. 1627–40.CrossRef
3.
go back to reference Loftus, C.G., et al., Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflammatory bowel diseases, 2007. 13(3): p. 254–61.CrossRef Loftus, C.G., et al., Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflammatory bowel diseases, 2007. 13(3): p. 254–61.CrossRef
4.
go back to reference Langholz, E., et al., Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology, 1994. 107(1): p. 3–11.CrossRef Langholz, E., et al., Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology, 1994. 107(1): p. 3–11.CrossRef
5.
go back to reference Jani, N. and M.D. Regueiro, Medical therapy for ulcerative colitis. Gastroenterology clinics of North America, 2002. 31(1): p. 147–66.CrossRef Jani, N. and M.D. Regueiro, Medical therapy for ulcerative colitis. Gastroenterology clinics of North America, 2002. 31(1): p. 147–66.CrossRef
6.
go back to reference Cima, R.R. and J.H. Pemberton, Medical and Surgical Management of Chronic Ulcerative Colitis. JAMA Surgery, 2005. 140(3): p. 300–310. Cima, R.R. and J.H. Pemberton, Medical and Surgical Management of Chronic Ulcerative Colitis. JAMA Surgery, 2005. 140(3): p. 300–310.
7.
go back to reference Leijonmarck, C.E., P.G. Persson, and G. Hellers, Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut, 1990. 31(3): p. 329–33.CrossRef Leijonmarck, C.E., P.G. Persson, and G. Hellers, Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut, 1990. 31(3): p. 329–33.CrossRef
8.
go back to reference Farmer, R.G., K.A. Easley, and G.B. Rankin, Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Digestive diseases and sciences, 1993. 38(6): p. 1137–46.CrossRef Farmer, R.G., K.A. Easley, and G.B. Rankin, Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Digestive diseases and sciences, 1993. 38(6): p. 1137–46.CrossRef
9.
go back to reference Ko, C.W., et al., AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology, 2019. 156(3): p. 748–764.CrossRef Ko, C.W., et al., AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology, 2019. 156(3): p. 748–764.CrossRef
10.
go back to reference Øresland, T., et al., European evidence based consensus on surgery for ulcerative colitis. Journal of Crohn's and Colitis, 2014. 9(1): p. 4–25.CrossRef Øresland, T., et al., European evidence based consensus on surgery for ulcerative colitis. Journal of Crohn's and Colitis, 2014. 9(1): p. 4–25.CrossRef
11.
go back to reference Thorne, K., et al., Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review. European journal of gastroenterology & hepatology, 2016. 28(4): p. 369–82.CrossRef Thorne, K., et al., Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review. European journal of gastroenterology & hepatology, 2016. 28(4): p. 369–82.CrossRef
12.
go back to reference Parragi, L., et al., Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study. Journal of Crohn's & colitis, 2018. 12(7): p. 811–818.CrossRef Parragi, L., et al., Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study. Journal of Crohn's & colitis, 2018. 12(7): p. 811–818.CrossRef
13.
go back to reference Murthy, S.K., et al., High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study. PloS one, 2017. 12(5): p. e0177211.CrossRef Murthy, S.K., et al., High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study. PloS one, 2017. 12(5): p. e0177211.CrossRef
14.
go back to reference Khera, R. and H.M. Krumholz, With Great Power Comes Great Responsibility: Big Data Research From the National Inpatient Sample. Circulation. Cardiovascular quality and outcomes, 2017. 10(7): p. e003846. Khera, R. and H.M. Krumholz, With Great Power Comes Great Responsibility: Big Data Research From the National Inpatient Sample. Circulation. Cardiovascular quality and outcomes, 2017. 10(7): p. e003846.
15.
go back to reference Deyo, R.A., D.C. Cherkin, and M.A. Ciol, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol, 1992. 45(6): p. 613–9.CrossRef Deyo, R.A., D.C. Cherkin, and M.A. Ciol, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol, 1992. 45(6): p. 613–9.CrossRef
16.
go back to reference Bewtra, M., C. Su, and J.D. Lewis, Trends in Hospitalization Rates for Inflammatory Bowel Disease in the United States. Clinical Gastroenterology and Hepatology, 2007. 5(5): p. 597–601.e1.CrossRef Bewtra, M., C. Su, and J.D. Lewis, Trends in Hospitalization Rates for Inflammatory Bowel Disease in the United States. Clinical Gastroenterology and Hepatology, 2007. 5(5): p. 597–601.e1.CrossRef
17.
go back to reference Smyth, C.M., et al., Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996–2001. Irish Journal of Medical Science, 2005. 174(4): p. 28.CrossRef Smyth, C.M., et al., Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996–2001. Irish Journal of Medical Science, 2005. 174(4): p. 28.CrossRef
18.
go back to reference Rawla, P. and T. Sunkara, Trends of Hospitalization in Ulcerative Colitis in Patients in the United States from 2000-2014. Conference poster presented at Advances in Inflammotory Bowel Diseases 2018, Orlando, Florida. Rawla, P. and T. Sunkara, Trends of Hospitalization in Ulcerative Colitis in Patients in the United States from 2000-2014. Conference poster presented at Advances in Inflammotory Bowel Diseases 2018, Orlando, Florida.
19.
go back to reference Dias, C.C., et al., Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019. 51(7): p. 952–960.CrossRef Dias, C.C., et al., Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019. 51(7): p. 952–960.CrossRef
20.
go back to reference Askling, J., et al., Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Annals of the rheumatic diseases, 2007. 66(10): p. 1339–44.CrossRef Askling, J., et al., Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Annals of the rheumatic diseases, 2007. 66(10): p. 1339–44.CrossRef
21.
go back to reference Kaplan, G.G., et al., Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. The American journal of gastroenterology, 2012. 107(12): p. 1879–87.CrossRef Kaplan, G.G., et al., Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. The American journal of gastroenterology, 2012. 107(12): p. 1879–87.CrossRef
22.
go back to reference Xu, F., et al., Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States. Applied health economics and health policy, 2019. 17(1): p. 77–91.CrossRef Xu, F., et al., Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States. Applied health economics and health policy, 2019. 17(1): p. 77–91.CrossRef
23.
go back to reference Klabunde, C.N., J.L. Warren, and J.M. Legler, Assessing comorbidity using claims data: an overview. Med Care, 2002. 40(8 Suppl): p. Iv-26-35. Klabunde, C.N., J.L. Warren, and J.M. Legler, Assessing comorbidity using claims data: an overview. Med Care, 2002. 40(8 Suppl): p. Iv-26-35.
Metadata
Title
Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?
Authors
Hassan Ghoz
Alex Kesler
Sanne A. Hoogenboom
Filippo Gavi
Bhaumik Brahmbhatt
John Cangemi
Paul T. Kröner
Publication date
01-02-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 2/2020
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-019-04474-9

Other articles of this Issue 2/2020

Journal of Gastrointestinal Surgery 2/2020 Go to the issue